Skip to Content


In the US, Zometa (zoledronic acid systemic) is a member of the drug class bisphosphonates and is used to treat Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Osteoporosis and Paget's Disease.

US matches:

UK matches:

Ingredient matches for Zometa

Zoledronic Acid

Zoledronic Acid is reported as an ingredient of Zometa in the following countries:

  • Argentina
  • Bangladesh
  • Belgium
  • Brazil
  • Canada
  • Chile
  • China
  • Cyprus
  • Egypt
  • Georgia
  • Greece
  • Hong Kong
  • Indonesia
  • Lebanon
  • Philippines
  • Poland
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Tunisia
  • United States

Zoledronic Acid monohydrate (a derivative of Zoledronic Acid) is reported as an ingredient of Zometa in the following countries:

  • Australia
  • Bosnia & Herzegowina
  • Croatia (Hrvatska)
  • Cyprus
  • Czech Republic
  • Ecuador
  • Estonia
  • France
  • Ireland
  • Italy
  • Lithuania
  • Macedonia
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Paraguay
  • Peru
  • Portugal
  • Serbia
  • Slovenia
  • South Africa
  • South Korea
  • Sweden
  • Turkey
  • United Kingdom
  • Uruguay
  • Venezuela

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.